Stress Dynamics and Familial Risk for Depression in Female Adolescents

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age13-15
SponsorMclean Hospital

About this trial

Stress and a parental history of major depressive disorder (MDD) are among the strongest risk factors for future development of MDD. Studies have shown that having a parental history of MDD may be associated with behavioral, psychophysiological, and hormonal responses to stress that are associated with poorer stress coping. . Adolescence is a vulnerable developmental window linked to increased MDD risk, especially for females, as rates of MDD surge relative to males. Despite the central role of stress in MDD onset, little is known about the brain mechanisms underlying stress responses in susceptible female adolescents at high familial risk for MDD. Also, it is unclear how stress-related brain network alterations may relate to "real-world" maladaptive stress responses and whether these stress-related brain network changes are predictive of future depression onset. We will fulfill these research gaps by combining neuroimaging with intensive longitudinal tracking of depressive symptomology as well as behavioral and physiological responses to "real world" stress using smartphone and smartwatch technology. Elucidating these neural mechanisms may aid in the discovery of MDD biomarkers that could identify youth at greatest risk for future MDD development and lead to earlier intervention efforts.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Female sex assigned at birth

Ages 13-15

English as first language or English Fluency

Right-handed

Disqualifiers

Cardiac pacemakers

Metal clips on blood vessels (also called stents)

Artificial heart valve, artificial arms, hands, legs, etc.

Brain stimulator devices

Trial design

Design model

Single group

Treatments tested in this trial

  • Computer Task Manipulation

    Behavioral

    Participants will complete computer tasks.

Treatment groups

148 Participants
are divided into 1 treatment group
Group A: Computer Task ManipulationExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Time Spent in Default Mode-Frontoparietal Network Coactivation Pattern (CAP)

Time Spent in Default Mode-Frontoparietal Network Coactivation Pattern (CAP). An fMRI variable. (the number of volumes spent in this CAP).

Time frame
Throughout a 1.75 hour MRI scan collected during the middle of a 3.5 hour 2nd study session
2

Persistence in default mode network-frontoparietal network co-activation pattern

Persistence in default mode network-frontoparietal network CAP. An fMRI measure. (the average number of consecutive volumes spent in this CAP)

Time frame
Throughout a 1.75 hour MRI scan collected during the middle of a 3.5 hour 2nd study session
3

Depressive Symptoms

The total score on the Mood and Feelings Questionnaire \[Min Score: 0, Max Score: 66, higher scores mean more severe depressive symptoms)

Time frame
Collected at baseline, the beginning of a 1.75 hour MRI, and at 6-, 12-, and 18-month follow-ups

Secondary outcomes

1

Cortisol

Saliva rating to be collected throughout the fMRI brain scan

Time frame
Collected throughout a 3.5 hour second study session that involves a 1.75 hour MRI conducted at the middle of the session
2

Stress Ratings

Stress ratings (0-100 sliding bar scale) collected via smartphone.

Time frame
Collected during a two-week period immediately after the 2nd study session (i.e., the MRI session), and then in the two-weeks immediately after the 6-, 12-, and 18-month follow-up sessions, respectively
3

Average heart rate (beats per minute)

compute average heart rate through smartwatch technology

Time frame
Collected during a two-week period immediately after the 2nd study session (i.e., the MRI session), and then in the two-weeks immediately after the 6-, 12-, and 18-month follow-up sessions, respectively
4

heart rate variability

heart rate variability expressed as the root mean square of successive differences (RMSSD)

Time frame
Collected during a two-week period immediately after the 2nd study session (i.e., the MRI session), and then in the two-weeks immediately after the 6-, 12-, and 18-month follow-up sessions, respectively

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Mclean Hospital

Lead sponsor

National Institute of Mental Health (NIMH)

Collaborator